DENVER–(BUSINESS WIRE)–Today ClinOne announced a strategic partnership with CQuentia to bring focused and personalized molecular testing to clinical trial patients. ClinOne’s mission is to simplify and accelerate clinical trials for those conducting, participating in and benefiting from clinical studies in onsite, remote, and strictly virtual settings. “Our goal is to increase patient access to life changing clinical trials, while continually analyzing operations and developing workflows and capabilities to minimize our clients’ costs,” explains Rob Bohacs, ClinOne’s CEO. Partnering with a laboratory such as CQuentia, provides a depth of diagnostic testing that expands ClinOne’s offering and brings comprehensive lab solutions directly to the patients.
ClinOne continuously evaluates the market for innovative companies and products to add to its suite of e-clinical technologies. “CQuentia is a thought leader in genomic testing and a natural fit, given their comprehensive COVID-19 testing capabilities offered at or near patients’ homes,” explains Dr. Elizabeth